TRIM9 Antikörper (AA 1-550) (FITC)
Kurzübersicht für TRIM9 Antikörper (AA 1-550) (FITC) (ABIN7151290)
Target
Alle TRIM9 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 1-550
-
Kreuzreaktivität
- Human
-
Aufreinigung
- >95%, Protein G purified
-
Immunogen
- Recombinant Human E3 ubiquitin-protein ligase TRIM9 protein (1-550AA)
-
Isotyp
- IgG
-
-
-
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4 -
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C,-80 °C
-
Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- TRIM9 (Tripartite Motif Containing 9 (TRIM9))
-
Andere Bezeichnung
- TRIM9
-
Hintergrund
-
Background: E3 ubiquitin-protein ligase which ubiquitinates itself in cooperation with an E2 enzyme UBE2D2/UBC4 and serves as a targeting signal for proteasomal degradation. May play a role in regulation of neuronal functions and may also participate in the formation or breakdown of abnormal inclusions in neurodegenerative disorders. May act as a regulator of synaptic vesicle exocytosis by controlling the availability of SNAP25 for the SNARE complex formation.
Aliases: TRIM9 antibody, KIAA0282 antibody, RNF91 antibody, E3 ubiquitin-protein ligase TRIM9 antibody, EC 2.3.2.27 antibody, RING finger protein 91 antibody, RING-type E3 ubiquitin transferase TRIM9 antibody, Tripartite motif-containing protein 9 antibody
-
UniProt
- Q9C026
-
Pathways
- Synaptic Vesicle Exocytosis
Target
-